-
TACAN regulates mesenchymal versus amoeboid cell states in glioblastoma
https://braincanada.ca/fr/subventions-financées/tacan-regulates-mesenchymal-versus-amoeboid-cell-states-in-glioblastomaGlioblastoma Multiforme (GBM) is the most common and aggressive brain tumour in adults. Project Overview Glioblastoma Multiforme (GBM) is the most common and aggressive brain tumour in adults. Current treatment includes surgical resection, chemotherapy, and radiation. However, since GBM is...
-
TACKLing the challenges of PREsymptomatic sporadic Dementia – The TACKL-PRED Study
https://braincanada.ca/fr/subventions-financées/tackling-the-challenges-of-presymptomatic-sporadic-dementia-the-tackl-pred-studyDementia is becoming more prevalent with the aging of the baby boomer population and is imposing a major challenge to society, both from a financial and social perspective. Project Overview Dementia is becoming more prevalent with the aging of the baby boomer population and is imposing a major...
-
Tanycytes in sensory circumventricular organs
https://braincanada.ca/fr/subventions-financées/tanycytes-in-sensory-circumventricular-organsThe brain is isolated from the peripheral blood circulation by a barrier (ie the blood-brain barrier) that protects it from the entrance of harmful substances (pathogenic or inflammatory agents) and prevents excessive fluctuations in the levels of circulating molecules. Project Overview The brain...
-
Tanycytic structural plasticity in circumventricular organs underlies homeostatic brain-body communication
https://braincanada.ca/fr/subventions-financées/tanycytic-structural-plasticity-in-circumventricular-organs-underlies-homeostatic-brain-body-communicationMetabolic syndrome is a group of risk factors (obesity, hypertension, high fasting blood sugar, and high levels of triglycerides) that increase the risk of type 2 diabetes and cardiovascular diseases. Project Overview Metabolic syndrome is a group of risk factors (obesity, hypertension, high...
-
Targeting a keystone bacterial periodontal pathogen to mitigate neurodegenerative changes in Alzheimer’s disease
https://braincanada.ca/fr/subventions-financées/targeting-a-keystone-bacterial-periodontal-pathogen-to-mitigate-neurodegenerative-changes-in-alzheimer-s-diseasePeriodontal disease has links with Alzheimer’s disease. Project Overview Periodontal disease has links with Alzheimer’s disease. The bacterium Porphyromonas gingivalis plays a major role in gum disease and has been associated with Alzheimer’s disease. We have identified a small protein, produced by...
-
Targeting Amyloid Propagation in Alzheimer Disease: Structures, Immunology and Extracellular Vesicle Topology
https://braincanada.ca/fr/subventions-financées/targeting-amyloid-propagation-in-alzheimer-disease-structures-immunology-and-extracellular-vesicle-topologyA treatment or prevention of Alzheimer’s disease is a top priority for medical science. Project Overview A treatment or prevention of Alzheimer’s disease is a top priority for medical science. Small aggregates of the protein amyloid-beta (A-beta), called oligomers, have been identified as being the...
-
Targeting Cryptic Exon Inclusion to Modify the G3BP1 Interactome in Amyotrophic Lateral Sclerosis
https://braincanada.ca/fr/subventions-financées/targeting-cryptic-exon-inclusion-to-modify-the-g3bp1-interactome-in-amyotrophic-lateral-sclerosisAmyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia (FTD) are devastating diseases in which a protein called TDP-43 ends up in the wrong part of the cell, disrupting its normal role in managing RNA. Project Overview Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia (FTD)...
-
Targeting GRP78 palmitoylation in glioblastomas
https://braincanada.ca/fr/subventions-financées/targeting-grp78-palmitoylation-in-glioblastomasGlioblastoma multiforme (GBM) the most common form of brain cancer in adults with very low survival of only 15 months with less than 5% of patients surviving more than 5 years. Surgery, chemotherapy, and radiation are the treatments currently used but recurrence is very common, often with tumors...
-
Targeting KCC2 for rescuing functional impairments in Alzheimer’s disease
https://braincanada.ca/fr/subventions-financées/targeting-kcc2-for-rescuing-functional-impairments-in-alzheimer-s-diseaseWithin the brain, cells communicate by sending signals that either enhance or dampen the activity of other cells. Project Overview Background Within the brain, cells communicate by sending signals that either enhance or dampen the activity of other cells. Balancing these excitatory and inhibitory...
-
Targeting metabolic dysfunction in ALS
https://braincanada.ca/fr/subventions-financées/targeting-metabolic-dysfunction-in-alsAmyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disease with distinct genetic contributions. Project Overview Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disease with distinct genetic contributions. However, even for genetically defined components of...